Results 161 to 170 of about 154,650 (346)

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis [PDF]

open access: yes, 2007
Non-alcoholic fatty liver disease comprises a spectrum of diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, and cirrhosis.
LIRUSSI, FLAVIO   +3 more
core   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Корекція ендотоксикозу і синдрому пероксидації у хворих на подагру в поєднанні з неалкогольним стеатогепатитом = Lipid peroxidation and endotoxemia syndrome сorrection in patients with gout combined with nonalcoholic steatohepatitis

open access: yesJournal of Education, Health and Sport, 2015
Smiyan S. I., Danchak S. V. Корекція ендотоксикозу і синдрому пероксидації у хворих на подагру в поєднанні з неалкогольним стеатогепатитом = Lipid peroxidation and endotoxemia syndrome сorrection in patients with gout combined with nonalcoholic ...
S. I. Smiyan, S. V. Danchak
doaj  

The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review

open access: yesТерапевтический архив
In September 2023, the European Association for the Study of the Liver (EASL) updated the disease nomenclature for non-alcoholic (metabolically associated) fatty liver disease.
Chavdar S. Pavlov   +9 more
doaj   +1 more source

Postoperative association between impaired renal function and vascular dysfunction in liver transplant recipients

open access: yes, 2022
Liver Transplantation, EarlyView.
Domenico A. Chavez   +8 more
wiley   +1 more source

Gallic acid mitigates high-fat and high-carbohydrate diet-induced steatohepatitis by modulating the IRF6/PPARγ signaling pathway

open access: yesFrontiers in Pharmacology
Gallic acid (GA), a natural organic phenolic compound, is an abundant plant food bioactive substance present in many medicinal herbs. GA has anti-oxidative, anti-inflammatory and anticancer activities on multiple metabolic disorders.
Jiahao Qiu   +20 more
doaj   +1 more source

Influence of antidysbiotic drugs on the liver of rats with experimental non-alcoholic steatohepatitis

open access: yesJournal of Education, Health and Sport, 2017
High-fat diets combined with the introduction of lincomycin causes the development of steatohepatitis. Introduction antidysbiotic drugs (pro- and prebiotics) has a therapeutic effect.
A. P. Levitsky   +2 more
doaj  

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.

open access: yes, 2003
The MCD model of 'fibrosing steatohepatitis' replicates the histologic features of human steatohepatitis, and the sequence of steatosis, inflammatory cell injury and fibrogenesis.
Phung, Nghi   +5 more
core   +1 more source

Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.

open access: yes, 2013
Nonalcoholic steatohepatitis affects up to 20 % of patients with resectable intrahepatic ...
Barroso, Eduardo   +43 more
core   +1 more source

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.

open access: yes, 2009
Recurrence of the original disease following liver transplantation is not uncommon and can lead to graft failure. There are limited data on recurrent fatty liver disease following liver transplantation.
Malik, Shahid, MD   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy